Critical IllnessNCT02454257
Risk Modelling for Quality Improvement in the Critically Ill: Making Best Use of Routinely Available Data
An observational study of Critical Illness and Heart Arrest, run by Intensive Care National Audit & Research Centre.
Trial summary
The aim of the proposed study is to better understand the epidemiology of, risk factors for and consequences of critical illness leading to improvements in the risk models used to underpin national clinical audits for adult general critical care, cardiothoracic critical care and in-hospital cardiac arrest using data… Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Critical Illness, Heart Arrest
- How many people
- 1,007,147 participants
- Where
- No sites listed yet
- Study dates
- 1 Aug 2015to 23 Dec 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Patients admitted to an adult critical care unit or cardiothoracic critical care unit or experiencing an in-hospital cardiac arrest in an NHS acute hospital in England or Wales.
Who may be able to join
- Admission to an adult critical care unit or cardiothoracic critical care unit or in-hospital cardiac arrest
Who cannot join
- None
About this study
The aim of the proposed study is to better understand the epidemiology of, risk factors for and consequences of critical illness leading to improvements in the risk models used to underpin national clinical audits for adult general critical care, cardiothoracic critical care and in-hospital cardiac arrest using data linkage with other routinely collected data sources.
Read the detailed description
Aim: To improve risk models used to underpin national clinical audits for adult general critical care, cardiothoracic critical care and in-hospital cardiac arrest using data linkage with other routinely collected data sources.
Specific objectives are:
- To improve risk models for adult general critical care by: (1a) developing risk models for mortality at fixed time-points and time-to event outcomes (by data linkage between the CMP and death registrations from ONS); developing risk models for longer term chronic health outcomes of (1b) diabetes (by data linkage between the CMP and the National Diabetes Audit) and (1c) end-stage renal disease (by data linkage between the CMP and the UK Renal Registry); and (1d) developing risk models for subsequent health care utilisation and costs (by data linkage between the CMP and HES)
- To improve risk models for cardiothoracic critical care by: (2a) enhancing risk factor data (by data linkage with the National Adult Cardiac Surgery Database); (2b) developing risk models for longer term mortality (by data linkage between the CMP and death registrations from ONS); and (2c) developing risk models for subsequent health care utilisation and costs (by data linkage between the CMP and HES)
- .To improve risk models for in-hospital cardiac arrest by: (3a) enhancing risk factor data (by data linkage between NCAA and HES); (3b) developing risk models for longer term mortality, health care utilisation and costs (by data linkage between NCAA and ONS); (3c) developing risk models for subsequent critical care utilisation (by data linkage between NCAA and CMP); and (3d) developing risk models for subsequent health care utilisation and costs (by data linkage between NCAA, ONS and HES)
- Immediate translation of the improved risk models into practice through: (4a) adoption into routine comparative outcome reporting for the national clinical audits; and (4b) communication of research output to providers, managers, commissioners, policy makers and academics in critical care
Data collection: The project will utilise high quality clinical data collected for the Case Mix Programme (CMP) and National Cardiac Arrest Audit (NCAA) - the national clinical audits for adult critical care and in-hospital cardiac arrest. These data will be linked with data from the National Diabetes Audit, UK Renal Registry and National Adult Cardiac Surgery Audit, routine administrative data from Hospital Episode Statistics (HES) and death registrations from the Office for National Statistics (ONS).
Data linkage will be undertaken by the HSCIC Data Linkage and Extract Service (DLES) acting as a trusted third party. Identifiers (with no associated clinical data) will be uploaded from each national clinical audit to secure servers at HSCIC. DLES will perform the data linkage and will return a common key that can be used to link all records of the same patient across the datasets. The three national clinical audits external to ICNARC will extract an agreed, pseudonymised dataset for linked records and DLES will extract data from HES and ONS and these datasets will be passed to ICNARC. ICNARC will produce pseudonymised data extracts from the CMP and NCAA and these will be linked to the datasets provided by the national clinical audits and DLES using the common key. In this way, only pseudonymised data will be linked between the multiple data sources.
Data analysis: The following approaches for model development will be applied depending on the outcome and objectives of the analysis:
- Modelling of mortality at fixed time-points (30 days, 90 days, 1 year) using logistic regression.
- Modelling of time-to-event outcomes using standard survival regression methods such as Weibull and Cox regression.
- To handle interval-censored data: Cox proportional hazards models, complementary log-log models using partial likelihood estimation (to permit interval censoring) and discrete-time hazard models.
- To account for both interval censoring of the time-to-onset and competition with death: Cause-specific Cox proportional hazards models and illness-death models will be considered.
- For Objective 3, return of spontaneous circulation (ROSC) for greater than 20 minutes and survival to hospital discharge outcome, multilevel logistic regression with random effects of hospital will be applied.
- To model Hospital resource use and costs post-critical care: multilevel regression model and Log linear regression model.
Risk prediction models will be validated for their discrimination, calibration and overall fit using a panel of measures including: c index; plots of observed against predicted risk; Hosmer-Lemeshow goodness-of-fit statistic; Cox's calibration regression; Shapiro's R, Brier's score and corresponding approximate R2 measures; and reclassification.
- Conditions
- Critical Illness, Heart Arrest
- Medical subject headings
- Critical Illness, Heart Arrest
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Admission to ICU | Patients admitted to an adult critical care unit or cardiothoracic critical care unit | |
| In-hospital cardiac arrest | Patients experiencing an in-hospital cardiac arrest |
What is being measured
The primary outcome is the main question the study is designed to answer.
All cause mortality
Measured: 30-days
All cause mortality
Measured: 90-days
All cause mortality
Measured: 1-year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 May 2015 (estimated)
- Study start1 Aug 2015
- Primary completion31 Mar 2016
- Study completion23 Dec 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Critical IllnessStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 1,007,147 participants (actual)
Sponsor and investigators
- Lead sponsor
- Intensive Care National Audit & Research Centre
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, David Harrison, Intensive Care National Audit & Research Centre
- Investigators
- David Harrison, MA PhD, Principal investigator, Head Statistician, ICNARC
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02454257
- Sponsor's protocol ID
- ICNARC/02/07/15
- Status last verified
- Jan 2023
- First submitted
- 20 May 2015
- Last updated
- 9 Jan 2023
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- Yes: An anonymised study dataset will be available on request from the Chief Investigator, subject to any necessary approvals
Publications
Ferrando-Vivas P, Shankar-Hari M, Thomas K, Doidge JC, Caskey FJ, Forni L, Harris S, Ostermann M, Gornik I, Holman N, Lone N, Young B, Jenkins D, Webb S, Nolan JP, Soar J, Rowan KM, Harrison DA. Improving risk prediction model quality in the critically ill: data linkage study [Internet]. Southampton (UK): National Institute for Health and Care Research; 2022 Dec. Available from http://www.ncbi.nlm.nih.gov/books/NBK587779/
PubMed 36542744
Study at a glance
From the registry record, last updated by the sponsor on 9 Jan 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Risk Modelling for Quality Improvement in the Critically Ill: Making Best Use of Routinely Available Data
- ClinicalTrials.gov ID
- NCT02454257
- Acronym / sponsor ID
- ICNARC/02/07/15
- Conditions
- Critical Illness, Heart Arrest
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,007,147 participants (actual)
- Lead sponsor
- Intensive Care National Audit & Research CentreUniversity, hospital or other
- Study start
- 1 Aug 2015 (actual)
- Primary completion
- 31 Mar 2016 (actual)
- Study completion
- 23 Dec 2022 (actual)
- First posted
- 27 May 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of the proposed study is to better understand the epidemiology of, risk factors for and consequences of critical illness leading to improvements in the risk models used to underpin national clinical audits for adult general critical care, cardiothoracic critical care and in-hospital cardiac arrest using data linkage with other routinely collected data sources.
Detailed description
Aim: To improve risk models used to underpin national clinical audits for adult general critical care, cardiothoracic critical care and in-hospital cardiac arrest using data linkage with other routinely collected data sources.
Specific objectives are:
- To improve risk models for adult general critical care by: (1a) developing risk models for mortality at fixed time-points and time-to event outcomes (by data linkage between the CMP and death registrations from ONS); developing risk models for longer term chronic health outcomes of (1b) diabetes (by data linkage between the CMP and the National Diabetes Audit) and (1c) end-stage renal disease (by data linkage between the CMP and the UK Renal Registry); and (1d) developing risk models for subsequent health care utilisation and costs (by data linkage between the CMP and HES)
- To improve risk models for cardiothoracic critical care by: (2a) enhancing risk factor data (by data linkage with the National Adult Cardiac Surgery Database); (2b) developing risk models for longer term mortality (by data linkage between the CMP and death registrations from ONS); and (2c) developing risk models for subsequent health care utilisation and costs (by data linkage between the CMP and HES)
- .To improve risk models for in-hospital cardiac arrest by: (3a) enhancing risk factor data (by data linkage between NCAA and HES); (3b) developing risk models for longer term mortality, health care utilisation and costs (by data linkage between NCAA and ONS); (3c) developing risk models for subsequent critical care utilisation (by data linkage between NCAA and CMP); and (3d) developing risk models for subsequent health care utilisation and costs (by data linkage between NCAA, ONS and HES)
- Immediate translation of the improved risk models into practice through: (4a) adoption into routine comparative outcome reporting for the national clinical audits; and (4b) communication of research output to providers, managers, commissioners, policy makers and academics in critical care
Data collection: The project will utilise high quality clinical data collected for the Case Mix Programme (CMP) and National Cardiac Arrest Audit (NCAA) - the national clinical audits for adult critical care and in-hospital cardiac arrest. These data will be linked with data from the National Diabetes Audit, UK Renal Registry and National Adult Cardiac Surgery Audit, routine administrative data from Hospital Episode Statistics (HES) and death registrations from the Office for National Statistics (ONS).
Data linkage will be undertaken by the HSCIC Data Linkage and Extract Service (DLES) acting as a trusted third party. Identifiers (with no associated clinical data) will be uploaded from each national clinical audit to secure servers at HSCIC. DLES will perform the data linkage and will return a common key that can be used to link all records of the same patient across the datasets. The three national clinical audits external to ICNARC will extract an agreed, pseudonymised dataset for linked records and DLES will extract data from HES and ONS and these datasets will be passed to ICNARC. ICNARC will produce pseudonymised data extracts from the CMP and NCAA and these will be linked to the datasets provided by the national clinical audits and DLES using the common key. In this way, only pseudonymised data will be linked between the multiple data sources.
Data analysis: The following approaches for model development will be applied depending on the outcome and objectives of the analysis:
- Modelling of mortality at fixed time-points (30 days, 90 days, 1 year) using logistic regression.
- Modelling of time-to-event outcomes using standard survival regression methods such as Weibull and Cox regression.
- To handle interval-censored data: Cox proportional hazards models, complementary log-log models using partial likelihood estimation (to permit interval censoring) and discrete-time hazard models.
- To account for both interval censoring of the time-to-onset and competition with death: Cause-specific Cox proportional hazards models and illness-death models will be considered.
- For Objective 3, return of spontaneous circulation (ROSC) for greater than 20 minutes and survival to hospital discharge outcome, multilevel logistic regression with random effects of hospital will be applied.
- To model Hospital resource use and costs post-critical care: multilevel regression model and Log linear regression model.
Risk prediction models will be validated for their discrimination, calibration and overall fit using a panel of measures including: c index; plots of observed against predicted risk; Hosmer-Lemeshow goodness-of-fit statistic; Cox's calibration regression; Shapiro's R, Brier's score and corresponding approximate R2 measures; and reclassification.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Admission to ICU | – | –Patients admitted to an adult critical care unit or cardiothoracic critical care unit |
| In-hospital cardiac arrest | – | –Patients experiencing an in-hospital cardiac arrest |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Patients admitted to an adult critical care unit or cardiothoracic critical care unit or experiencing an in-hospital cardiac arrest in an NHS acute hospital in England or Wales.
Key inclusion criteria (1 listed)
- Admission to an adult critical care unit or cardiothoracic critical care unit or in-hospital cardiac arrest
Key exclusion criteria (1 listed)
- None
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
All cause mortality
Time frame: 30-days
All cause mortality
Time frame: 90-days
All cause mortality
Time frame: 1-year
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Jan 2023.
- Results publication: PubMed 36542744Ferrando-Vivas P, Shankar-Hari M, Thomas K, Doidge JC, Caskey FJ, Forni L, Harris S, Ostermann M, Gornik I, Holman N, Lone N, Young B, Jenkins D, Webb S, Nolan JP, Soar J, Rowan KM, Harrison DA. Improving risk prediction model quality in the critically ill: data linkage study [Internet]. Southampton (UK): National Institute for Health and Care Research; 2022 Dec. Available from http://www.ncbi.nlm.nih.gov/books/NBK587779/
- Funding detailsLink provided by the sponsor.
- Individual participant dataSharing planned: Yes. An anonymised study dataset will be available on request from the Chief Investigator, subject to any necessary approvals
Related trials for Critical Illness
Recruiting
KInetics of Procalcitonin to Reduce Unnecessary aNtibiotic Use - Comparing Procalcitonin Kinetics-guided and Absolute Procalcitonin Value-guided Antibiotic Initiation in Reducing Unnecessary Antibiotic Use in Critically Ill Patients
Infection, Sepsis
Not yet recruitingObservational study
Capillary Refill Time Variation to Predict Oxygen Comsumption Variation After FLuid Challenge (CARTOFL)
Critically Ill Patients, Circulatory Shock
RecruitingPhase 4
CONTinuous Infusion Versus Intermittent Dosing of ceftaZidime/AVIbactam in Critically Ill Patients
Severe Infection
Not yet recruitingObservational study
Lactate/Albumin Ratio and Mortality in Respiratory Failure
Acute Respiratory Failure, Critical Illness
RecruitingObservational study
Respiratory Physiotherapy and Inflammatory Biomarkers in Critically Ill Patients With Pneumonia
Pneumonia, Critical Illness
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
David Harrison, MA PhD principal investigator
Head Statistician, ICNARC
Questions about this trial
What is this clinical trial studying?
An observational study of Critical Illness and Heart Arrest, run by Intensive Care National Audit & Research Centre.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
All cause mortality (time frame: 30-days). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02454257, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jan 2023.